Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Developing Pfs230-Pfs48/45 Fusion Proteins as Possible Malaria Transmission Blocking Vaccine Candidates

FY 2024-25

Summary
Malaria devastates thousands worldwide every year, and despite commercially available vaccines which aim to block the infectious stage of malaria, additional measures must be explored to fulfill the goal of global malaria elimination. A prominent bottleneck in the malaria life cycle is the transmission of mature malarial parasites from infected humans to non-infected mosquitos, and transmission-blocking vaccines target this particular stage. Two prominent surface proteins involved in malaria transmission, Pfs230 and Pfs48/45 possess several domains with antigenic potential. Domain 1 (D1) of both proteins contain structural similarities, which allowed them to be fused together by members of the Julien lab. This fusion produced proteins with both D1 antigenic epitopes of Pfs230 and Pfs48/45, allowing for the resulting immune response of both antigens to be produced from a single protein. However, the stability, immunogenicity, and potential for multimerization of the Pfs230-Pfs48/45 D1 fusion proteins has yet to be investigated. Through my research, I aim to optimize the structure stability of D1 fusion proteins, through the expression, purification, and refinement of constructs. Following this, mice immunization studies will be pursued to determine the immunogenicity of these proteins, and identify lead candidates. These candidates will then be displayed on various nanoparticles, exploring the effect of different geometries and orientations on multimerization and the resulting immunogenic effect. Lastly, the nanoparticles displaying the D1 fusion proteins will be assessed for their transmission reducing ability in mosquitos. This research aims to generate a potential malaria transmission-blocking candidate through protein engineering and in-vivo analysis.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530149
Name
Dhindsa Amrita
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developing Pfs230-Pfs48/45 Fusion Proteins as Possible Malaria Transmission Blocking Vaccine Candidates
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biochemistry; Immunology; Malaria; Protein Engineering; Structure-Guided Design; Translation; Vaccines
Abstract
Malaria devastates thousands worldwide every year, and despite commercially available vaccines which aim to block the infectious stage of malaria, additional measures must be explored to fulfill the goal of global malaria elimination. A prominent bottleneck in the malaria life cycle is the transmission of mature malarial parasites from infected humans to non-infected mosquitos, and transmission-blocking vaccines target this particular stage. Two prominent surface proteins involved in malaria transmission, Pfs230 and Pfs48/45 possess several domains with antigenic potential. Domain 1 (D1) of both proteins contain structural similarities, which allowed them to be fused together by members of the Julien lab. This fusion produced proteins with both D1 antigenic epitopes of Pfs230 and Pfs48/45, allowing for the resulting immune response of both antigens to be produced from a single protein. However, the stability, immunogenicity, and potential for multimerization of the Pfs230-Pfs48/45 D1 fusion proteins has yet to be investigated. Through my research, I aim to optimize the structure stability of D1 fusion proteins, through the expression, purification, and refinement of constructs. Following this, mice immunization studies will be pursued to determine the immunogenicity of these proteins, and identify lead candidates. These candidates will then be displayed on various nanoparticles, exploring the effect of different geometries and orientations on multimerization and the resulting immunogenic effect. Lastly, the nanoparticles displaying the D1 fusion proteins will be assessed for their transmission reducing ability in mosquitos. This research aims to generate a potential malaria transmission-blocking candidate through protein engineering and in-vivo analysis.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dhindsa, Amrita
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~